First new HIV vaccine efficacy study in 7 years has begun: The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves a new version of the only HIV vaccine candidate ever shown to provide some protection against the … [Read more...] about First new HIV vaccine efficacy study in 7 years has begun
vaccine
SA News: New HIV vaccine trial to start in South Africa
New HIV vaccine trial to start in South Africa: A new vaccine against HIV, to be tested in a trial to be launched in South Africa Wednesday, could be "the final nail in the coffin" for the disease if it is successful, scientists say. The study, called HVTN 702, aims to enroll 5,400 sexually active men ... Source: "South Africa" - BingNews Australia beat South Africa by … [Read more...] about SA News: New HIV vaccine trial to start in South Africa
Explainer: the how, what and why of the latest HIV vaccine trial | The Conversation
Explainer: the how, what and why of the latest HIV vaccine trial: ShutterstockAs the global quest for an HIV vaccine continues, Linda-Gail Bekker explains the significance of the latest large-scale trial underway in South Africa. What’s the significance of the trial for the global fight against HIV? The world needs an HIV vaccine. Our prevention … [Read more...] about Explainer: the how, what and why of the latest HIV vaccine trial | The Conversation
Why its still worth getting the flu vaccine this year | The Conversation
Why its still worth getting the flu vaccine this year: ShutterstockInfluenza, more commonly known as flu, kills between 6,000 and 11,000 South Africans every year. About half of those deaths are in the elderly and about 30% in HIV-infected people. During the flu season in South Africa about 14% of patients hospitalised for pneumonia and 25% of … [Read more...] about Why its still worth getting the flu vaccine this year | The Conversation
